Drug combo shows promise for hard-to-treat gynecological cancers
The combination of nivolumab and ipilimumab led to a 54% response rate in patients with advanced gynecological clear cell cancers.
News
-
-
Childhood obesity is associated with an increased risk of developing endometrial cancer
A high childhood BMI is associated with an increased risk of developing endometrial cancer.
-
Heavy metal exposure may increase risk of endometrial cancer
A recent study investigated the role that heavy metals, a known environmental hazard, may play in the development of endometrial cancer.
-
Trial of potential endometrial cancer therapy to be completed soon
A clinical trial aiming to assess the effectiveness of abemaciclib in patients with EC will reach its primary completion date in July 2025.
-
AI may help identify patients at risk of endometrial cancer
Learn more about how AI can help identify patients at risk of endometrial cancer by streamlining data analysis, medical imaging and more.
-
Study: Racial disparities in endometrial cancer may have genetic basis
A new study identified several genes that are differentially mutated in Black versus white patients with EC.
-
Insufficient endometrial biopsy may increase risk of endometrial cancer
A recent study found patients who have an insufficient or incomplete endometrial biopsy may be at increased risk of developing EC.
-
Scientists pinpoint key protein that could help treat endometrial cancer
ZNF432 slowed the growth of endometrial cancer cells and promoted their death by interacting with a protein called UPF1.
